# Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study

Study · id `cardio:ct-nct03720639` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03720639](<https://clinicaltrials.gov/study/NCT03720639>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03720639

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 209 participants.

## Technical summary

Registry record NCT03720639. Randomized; no masking; primary purpose diagnostic. Start 2018-05-18 (actual); primary completion 2020-03-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 209 participants (enrolled count; ClinicalTrials.gov record NCT03720639, source copy `cardio:ctgov-nct03720639-2020-03-10`, retrieved 2026-10-26)
- Started: 2018-05-18 (actual) (ClinicalTrials.gov record NCT03720639, source copy `cardio:ctgov-nct03720639-2020-03-10`, retrieved 2026-10-26)
- Primary completion: 2020-03-09 (actual) (ClinicalTrials.gov record NCT03720639, source copy `cardio:ctgov-nct03720639-2020-03-10`, retrieved 2026-10-26)
- Completion: 2020-03-09 (actual) (ClinicalTrials.gov record NCT03720639, source copy `cardio:ctgov-nct03720639-2020-03-10`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03720639, source copy `cardio:ctgov-nct03720639-2020-03-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03720639-2020-03-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study
- Condition: Cardiac Arrythmias
- Condition: Syncope
- Condition: Atrial Fibrillation
- Condition: Atrial Flutter
- Condition: Tachycardia
- Condition: Stroke
- Intervention (Device): Abbott, Inc Confirm Rx™ versus Medtronic, Inc Reveal LINQTM
- Lead sponsor: Sparrow Clinical Research Institute
- Lead sponsor class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: 09b606e1e22baddadc197144d8a2b6a79cafdd995f12857816e2175366f69917
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
